Pub. Date : 2019
PMID : 31448223
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | This includes the use asciminib as first in class inhibitor targeting the myristoyl pocket of BCR-ABL, combination treatments with established non-TKI drugs such as interferon and drugs with novel targets relevant to CML biology such as gliptins and thiazolidinediones. | asciminib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |